01069 CN HEALTH TECH
- 0.082
- +0.026+46.43%
CN HEALTH TECH News
China Health Technology Group Terminates 52% Stake Acquisition Deal
China Health Technology Group Holding (HKG:1069) will terminate the acquisition deal for a 52% stake in a target company, according to a Hong Kong bourse filing on Monday. The termination is mutually
China Health Technology Group (01069.HK) terminated the acquisition of 52% shares in Liuba Jiashisen Traditional Chinese Medicine Comprehensive Development
Gelonghui, April 8, 丨 China Health Technology Group (01069.HK) announced the acquisition of 52% of the shares in Liuba Jiashisen Traditional Chinese Medicine Comprehensive Development. After signing the share sale agreement, the company then carried out detailed due diligence and other work on the seller. However, at the company's request, the seller failed to provide satisfactory due diligence documentation to the company. Following friendly negotiations between the company and the seller, the contracting parties decided to terminate the acquisition. The Board believes that terminating the agreement will not have any significant adverse impact on the Group's business, operations, or financial position.
中國健康科技集團：二零二三年中期報告
China Health Technology Returns to Profit in Fiscal H1
China Health Technology Group (HKG:1069) returned to a profit of 201.4 million yuan in the six months ended Dec. 31, 2023, from a loss of 1.2 million yuan in the year-ago period, a Friday filing said.
China Health Technology Group (01069) announced interim results with net profit of 201 million yuan
China Health Technology Group (01069) announced results for the six months ended December 31, 2023, with revenue of 19...
CN HEALTH TECH: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2023
China Health Technology (01069.HK) held a board meeting on February 29 to consider and approve the interim results
Gelonghui, Feb. 19 | China Health Technology (01069.HK) announced that it will hold a board meeting on February 29, 2024 (Thursday) to consider and approve the Group's interim results announcement for the six months ended December 31, 2023, and to consider the proposed payment of an interim dividend (if any).
CN HEALTH TECH: DATE OF BOARD MEETING
China Health Technology Group CEO Resigns
China Health Technology Group (HKG:1069) Chief Executive Officer Chan Wai Lung stepped down effective Monday to attend to his other responsibilities, a same-day filing said. Wang Yibin, an executive d
China Health Technology Group (01069) appoints Wang Yibin as CEO
China Health Technology Group (01069) announced that Chen Weilong has resigned as he needs more time to handle other businesses...
China Health Technology Signs Tan Sheep Farming Business Agreement; Shares Rise 6%
China Health Technology Group (HKG:1069) signed a non-legally binding memorandum with Ningxia AL-AMINA Cloud Pasture Breeding for the development of a tan sheep business in China, a Wednesday filing s
China Health Technology Group (01069) plans to develop diversified trading business related to beach sheep with Ningxia Ketuo Shepherds
China Health Technology Group (01069) issued an announcement. On January 24, 2024, the company and Ningxia KeTuo Shepherd...
China Bozza Development Changes Name to China Health Technology
China Bozza Development Holdings (HKG:1069) officially changed its name to China Health Technology Group Holding after receiving a certificate of incorporation from the Cayman Islands' Registrar of Co
Baosha Development (01069) plans to change its stock abbreviation to “China Health Technology Group”
Baosha Development (01069) issued an announcement. At the annual shareholders' meeting held on November 21, 2023, shareholders...
Baosha Development (01069.HK) Stock Short Name Change Effective January 4
Gelonghui, December 29, 丨 Baosha Development (01069.HK) announced that it will take effect from 9:00 a.m. on January 4, 2024. For the purpose of trading the company's shares on the Hong Kong Stock Exchange Limited, the company's stock abbreviation will be changed from the English “BOZZA DEVELOP” to “CN HEALTH TECH” and from the Chinese “Baosha Development” to “China Health Technology Group”.
Bozza Development CEO Steps Down
China Bozza Development Holdings' (HKG:1069) Chief Executive Officer Li Wenjunb stepped down, effective Tuesday, a same-day filing said. Li's reelection as director was voted down during the forestry
Baossa Development (01069) appoints Chen Weilong as CEO
Baossa Development (01069) announced that Gu Sutong and Huang Kaiying will retire from the board of directors after the annual general meeting of shareholders. Because...
BOZZA DEVELOP: Annual Report 2023
BOZZA DEVELOP: CLARIFICATION ANNOUNCEMENT IN RELATION TO ANNUAL REPORTS
Bozza Development Holdings' Attributable Loss Narrows in Fiscal Year 2023
China Bozza Development Holdings' (HKG:1069) attributable loss narrowed to 10.8 million yuan, or 0.098 yuan per share, in the fiscal year ended June 30, from 18.9 million yuan, or 0.1714 yuan per shar
Analysis
Price Target
No Data
